A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder

American Journal of Clinical Nutrition

Volumn 64, Issue 3, 1996, Pages 267-273

  Greeno, Catherine G ^a,b   Wing, Rena R ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE   (United States)

Author keywords

appetite; binge eating; fluoxetine; Obesity

Indexed keywords

FLUOXETINE;

ADULT; APPETITE; ARTICLE; BODY WEIGHT; BULIMIA; CARBOHYDRATE INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; ENERGY CONSUMPTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOOD; OBESITY; RANDOMIZED CONTROLLED TRIAL; SATIETY; SINGLE BLIND PROCEDURE;

EID: 0029825108     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/64.3.267     Document Type: Article

References (27)

1. Darga LL, Carroll-Michals L, Botsford SJ, Lucas CP. Fluoxetine's effect on weight loss in obese subjects. Am J Clin Nutr 1991;54:321-5.
2. Kinney-Parker JL, Smith D, Ingle SF. Fluoxetine and weight: something lost and something gained? Clin Pharm 1989;8:727-33.
3. Marcus MD, Wing RR, Ewing L, Kern E, McDermott M, Gooding W. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-bingeeaters. Am J Psychiatry 1990;147:876-81.
4. Wise SD. Clinical studies with fluoxetine in obesity. Am J Clin Nutr 1992;55(suppl):181S-4S.
5. deJonghe G, Ravelli DP, Tuynman QH. A randomized, double-blind study of fluoxetine and naprotiline in the treatment of major depression. Pharmacopsychiatry 1991;24:62-7.
6. Fawcett J, Zajecka JM, Kravitz HM, et al. Fluoxetine versus amitriptyline in adult outpatients with major depression. Curr Ther Res 1989;45:821-32.
7. Meyerowitz W, Jaramillo JD. Antidepressant treatment and weight loss. Curr Ther Res 1992;52:169-74.
8. Nielsen BM, Behnke K, Arup P, et al. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder. Acta Psychiatr Scand 1993;87:269-72.
9. McGuirk J, Silverstone T. The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects. Int J Obes 1990;14:361-72.
10. Pijl H, Koppeschaar HPF, Willekens FLA, de Kamp IO, Veldhuis HD, Meinders AE. Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity. Int J Obes 1990;15:237-42.
11. Stinson JC, Murphy CM, Andrews JF, Tomkin GH. An assessment of the thermogenic effects of fluoxetine in obese subjects. Int J Obes 1992;16:391-5.
12. Leibowitz SF, Shor-Posner G. Hypothalamic monoamine systems for control of food intake: analysis of meal patterns and macronutrient selection. In: Carruba MO, Blundell JE, eds. Pharmacology of eating disorders: theoretical and clinical developments. New York: Raven Press, 1986:29-49.
13. Shor-Posner G, Grinker JA, Marinescu C, Brown O, Leibowitz SF. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res Bull 1986;17:663-71.
14. Blundell JE, Hill AJ. Do serotoninergic drugs decrease energy intake by reducing fat or carbohydrate intake? Effect of d-fenfluramine with supplemented weight-increasing diets. Pharmacol Biochem Behav 1989;31:773-8.
15. Fuller RW, Owen JE. Suppression of milk drinking by the combination of fluoxetine and L-5-hydroxytryptophan in rats. Res Commun Chem Pathol Pharmacol 1981;34:137-44.
16. Rowland NE, Antelman SM, Bartness TJ. Comparison of the effects of fenfluramine and other anorectic agents in different feeding and drinking paradigms in rats. Life Sci 1985;36:2295-300.
17. Wurtman JJ, Wurtman RJ. Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats. Science 1977;198:1178-80.
18. Kramer PD. Listening to Prozac: a psychiatrist explores mood altering drugs and the new meaning of the self. New York: Viking, 1993.
19. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992;49:139-47.
20. Greeno CG, Wing RR. Stress-induced eating. Psychol Bull 1994;115:444-68.
21. Chouinard G. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J Clin Psychiatry 1985;46:32-7.
22. Cohn JB, Wilcox C. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorders. J Clin Psychiatry 1985;46:26-31.
23. Feighner JP. Clinical efficacy of the new antidepressants. J Clin Pharmacol 1981;1:235-65.
24. Stark P, Hardison CD. A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985;46:53-8.
25. Cooper Z, Fairburn CG. The Eating Disorder Examination: a semi-structured interview for the assessment of the specific psychopathology of eating disorders. Int J Eat Disord 1987;6:1-8.
26. Fairburn CG, Cooper Z. The Eating Disorder Examination. 12th ed. In: Fairburn CG, Wilson GT. Binge eating: nature assessment and treatment. New York: Guilford Press, 1993:317-60.
27. Greeno CG, Marcus MD, Wing RR. Diagnosis of binge eating disorder: discrepancies between a questionnaire and clinical interview. Int J Eat Disord 1995;17:153-60.